Browse our resources

Diagnosis-level medical trend replaces the single blended assumption with granular claims analytics. Learn why health reinsurers now demand condition-specific trend rates for credible treaty pricing.

2026-07-27

Digital manufacturing files for 3D-printed products create liability exposure at every step from design file to finished item. Here's how reinsurers can trace digital design provenance.

2026-07-27

Digital therapeutics are creating new product-liability exposure as clinical apps get prescribed like drugs. Reinsurers must price software-as-medicine risk with the clinical evidence standards that regulatory frameworks demand.

2026-07-27

Drug-resistant fungal disease is an emerging infectious exposure health reinsurers cannot ignore. Learn how disease surveillance data reveals antifungal-resistance risk hiding in treaty portfolios.

2026-07-27

Early-onset cancer is shifting incidence curves younger, challenging life and critical illness reinsurance pricing assumptions. Learn how treaty underwriters can adapt their surveillance and repricing approach.

2026-07-27

EHR completeness vs. claims data is a critical question for life reinsurers when underwriting signals conflict. Learn how data provenance and reconciliation frameworks determine which source to trust for pricing and risk selection.

2026-07-27

EHR failure claims are emerging as a product-liability exposure where missing or corrupted data fields cause patient harm. Audit logs are becoming the evidence that decides reinsurance liability.

2026-07-27

The EU Product Liability Directive now treats software as a product. Discover how reinsurers map product-version traceability to price liability exposure from updates that cause physical harm.

2026-07-27

Extreme heat as a casualty liability event is redefining risk portfolios. Worker injury, premises liability, and product failure triggered by heat create exposure layers traditional property-focused modeling does not capture.

2026-07-27

Extreme heat drives health claims far beyond heatstroke. Learn how public-health surveillance data becomes treaty intelligence for pricing and reserving health reinsurance programs.

2026-07-27

Funded reinsurance recapture is reshaping collateral scrutiny. Learn why building look-through into asset pools before regulators demand stress tests separates prepared life carriers from scrambling ones.

2026-07-27

Generative AI copyright claims are creating accumulation risk in cyber and media liability treaties. Learn how training-data provenance reveals the hidden correlation that demands treaty-level attention.

2026-07-27

GLP-1 adherence, not prescription counts, reveals the true metabolic-risk signal life reinsurers need. Learn why refill patterns matter more than scripts for mortality pricing and treaty underwriting.

2026-07-27

The GLP-1 disclosure gap creates an evidence problem for life reinsurers. Learn how to design fair underwriting disclosure questions when applicants use GLP-1 drugs for weight management or diabetes.

2026-07-27

GLP-1 litigation is generating headlines that conflate drug-safety risk with media amplification. Learn how reinsurers can use litigation-signal analytics to separate genuine exposure from noise before reserving.

2026-07-27

The hair-relaxer litigation shows how docket monitoring detects mass torts early. Learn the blueprint reinsurers can use to catch the next consumer-product mass tort before it appears in the loss triangle.

2026-07-27

Healthcare fraud rings exploit fragmented claims review to compound losses. Learn how network analytics connects related fraudulent claims before they escalate into treaty-level recoveries.

2026-07-27

Human-trafficking claims are emerging as a material liability exposure in hospitality and transport portfolios. Learn how reinsurers are mapping trafficking litigation risk across cedents' books before reserving triangles capture it.

2026-07-27